Unit profile


Our main aim is to improve outcome for the painful and fatal tumor disease, multiple myeloma (MM). To do this we pursue three lines of research; i) use investigator initiated clinical trials to test prevention strategies and ii) test new drug combinations in clinical trials and iii) investigate phagocyte subsets and functions during treatment and progression of MM.


Markus Hansson is Research Leader for this research group

UKÄ subject classification

  • Hematology

Free keywords

  • myeloma
  • phagocyte
  • eosinophils
  • neutrophils
  • plasma cells
  • clinical trial

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or